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ABSTRACT
Resistance to antibiotics has become a major challenge in today’s society for
treating bacterial infections. Inhibition of quorum sensing has a potential to be a nonantibiotic based therapeutic that could be used to fight these bacterial infections. Quorum
sensing is a cell density dependent, intercellular communication mechanism that bacteria
use to synchronize behavior such as virulence and resistance to antibiotics. If this switch
from planktonic to communal behavior can be inhibited, the bacteria will be less virulent.
One possible way to accomplish this is by inhibiting the enzymes that are responsible for
making the quorum sensing signaling molecules in Gram-negative bacteria – acylhomoserine lactone (AHL) synthases. Since AHL synthases are mostly uncharacterized,
understanding how these enzymes recognize its acyl-substrate would be beneficial to
designing effective quorum sensing inhibitors. The focus of this thesis is to investigate the
substrate recognition mechanism in BjaI, an acyl-homoserine lactone synthase found in
soybean symbiont Bradyrhizobium japonicum. BjaI was chosen because it can be used to
highlight the differences between acyl-ACP vs acyl-CoA utilizing AHL synthases. We
found that all of our single point mutations within either of the substrate binding pockets,
S-adenosyl-L-methionine and isovaleryl-CoA, were detrimental to enzyme activity.
Kinetic constants were measured for the native and other similar non-native acyl-CoAs as
well as their respective alkyl-CoA inhibitors. For too long (> six carbons) and too short (<
four carbons) acyl-CoAs, we found that BjaI rejected nonspecific substrates at the binding
step. However, for substrates that are structurally similar to isovaleryl-CoA, BjaI uses a

v

combination of both the binding and catalytic steps to reject the nonspecific substrate. The
tools used in this study should open new doors to designing effective quorum sensing
inhibitors.
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CHAPTER ONE: INTRODUCTION
Quorum Sensing
Fighting off bacterial infections is becoming more challenging as antibiotics
develop resistance faster than they are being discovered.1, 2 Finding an alternative route to
fight off pathogenic bacteria is critical to addressing the drug resistance problem in
antibacterial therapy. Quorum sensing inhibition is a potential method that can aid in
controlling bacterial virulence without aggravating drug resistance.

Figure 1
Quorum sensing with bacterial cell density. A high concentration of
autoinducers is indicative of a higher population density of bacterial cells. When this
quorum has-been reached, the bacterial cells start behaving as a group entity instead
of a single cell.
Quorum sensing (QS) is a form of cell-to-cell communication that allows bacteria
to act as a multicellular organism.3-5 Using small molecules, known as autoinducers,
bacteria can “count” how many other bacterial cells there are in its vicinity where a high
concentration of autoinducers is indicative of a high population density (Figure 1). These
cell-permeable autoinducers allow the bacteria to coordinate gene expression, which in

2
turns regulates group behavior, including virulent gene expression, biofilm production, and
antibiotic resistance.6, 7 Preliminary data suggests that inhibition of quorum sensing does
decrease the virulence of that bacterium and has the potential to be used as a therapeutic
drug.8-11 What makes quorum sensing particularly interesting for antibacterial therapy is
inhibition of QS would not directly kill bacteria thereby exerting less pressure for the
microbe to develop drug resistance. Since autoinducers are species-specific, QS inhibitors
are attractive as tools to discover novel antibacterial drugs that do not promote drug
resistance.
Quorum sensing was first discovered in Vibrio fischeri during the 1970s, where the
bacteria offers bioluminescence as protection for a bobtail squid.12 The squid would use
the bioluminescent bacteria to hide its shadow and become more invisible to its
predators.13, 14 To be successful, the bacteria would have to become luminescent all at once
in a controlled manner, which is accomplished through quorum sensing. The expression of
the luciferase operon, which is responsible for bioluminescence, is controlled by two
proteins, LuxI and LuxR.3 The autoinducer, synthesized by the initiator enzyme (LuxI),
binds to the receptor protein (LuxR) to increase transcription of several genes that are
required for bioluminescence as well as other group behavioral factors, like virulence
production (Figure 2).15
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Figure 2
Autoinducer system for Gram-negative bacteria. An initiator enzyme
(belonging to the LuxI family) synthesizes autoinducers that can diffuse in and out of
the cell. Once bound to the receptor protein, either the release or binding of this
protein to the DNA regulate virulence gene expression.
There are different types of QS systems depending on the type of bacteria.3 As
described above, Gram-negative bacteria have initiator and receptor proteins that induce
QS. More specifically, Gram-negative bacteria use acyl-homoserine lactone (AHL)
synthases as their initiator enzymes, which are responsible for making their specific AHL
autoinducer.16 The difference in the signaling molecule lies within the acyl-chain, as shown
in Figure 3, in the acyl-ACP or acyl-CoA substrate. Most AHL synthases have narrow
substrate specificity, and therefore signal production specificity, so bacteria can
communicate within its own species without having other bacteria interfere. Some bacteria
have other methods to ensure signal fidelity. For example, the plant pathogen
Agrobacterium tumefaciens, have low half-lives of the receptor protein, TraR, unless it is
bound with the signaling molecule.17 This allows for the QS cascade to only occur when
there is a high enough concentration of the signaling molecule.3
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Specific acyl-substrate for certain acyl-homoserine lactone synthases.
This allows them to have intraspecies communication without interference from other
nonspecific autoinducers. The acyl-ACP substrate is derived from fatty acid
biosynthesis and acyl-CoAs are derived from CoA biosynthesis.
Autoinducers in Gram-positive bacteria are short cyclic or linear peptides that are
exported out of the cell and bind to cell membrane proteins.3, 18, 19 Unlike Gram-negative
bacteria, Gram-positive have a two component response system, usually with a membranebound histidine kinase and a response regulator.16, 20, 21 More specifically, the histidine
kinase will detect and interact with the autoinducer peptide (AIP), which causes a
phosphorylation cascade. During this process, the response regulator protein will become
activated, allowing it to bind to DNA and increase quorum sensing gene expression (Figure
4). The variation in these signaling molecules comes in the modification of the peptide
(Figure 5), which gives rise to specificity between bacteria.
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Figure 4
Autoinducer system in Gram-positive bacteria. Small peptides are
synthesized and modified for each specific Gram-positive bacterial species. These
peptides get transported out (A), bind to a histidine kinase (B), which then causes a
phosphorylation cascade. The response regulator gets activated through
phosphorylation, which then increases gene expression.
AHL’s and AIP’s are beneficial to bacteria because they allow the colony to be able
to communicate between themselves with less interference from neighboring colonies.
However, it can also be advantageous to work together with different bacteria. To facilitate
communication in this case, there is another type of signaling molecule, called autoinducerII (AI-II), which works more like a universal language between the many types of
bacteria.22 Each species can carry out a certain function benefitting the entire bacterial
population and they can do it in a controlled and organized fashion with AI-IIs (Figure 5).

6

Glu-Arg-Gly-Met-Thr

B. subtilis / CSF

Tyr

C

Cys

Ser

S. aureus / (AIP-I)

O

S

Thr

Met
Asp
Phe

S. aureus / (AIP-II)

Gly

S

Ala

Val

Ile

O
C

Cys

Asn

Phe
Ser
Ser

S. pneunomiae / CSP

Glu-Met-Arg-Leu-Ser-Lys-Phe-Arg-Asp-Phe-Ile-LeuGln-Arg-Lys-Lys

H3C
V. harveyi / AI-II

Leu

O

O
-

HO B O
HO

OH
OH

Figure 5
Examples of autoinducers in Gram-positive bacteria and structure of
an autoinducer-II molecule.

BjaI, an AHL Synthase found within the bacteria Bradyrhizobium japonicum
Rhizobium are Gram-negative soil bacteria that form symbiotic relationships with
plants. The bacteria will fix atmospheric nitrogen into ammonia and ammonium, which is
in a form that the plants can use, and in return the plants let the bacteria uptake some of its
carbohydrates.23 More specifically, Bradyrhizobium japonicum is commonly found within
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the root nodules of soybeans, where nitrogen fixation can occur.24 When the soil is low on
fixed nitrogen (nitrate, ammomia, urea, etc.) legumes will release flavonoids that signal to
rhizobia bacteria that they are needed.25 After the initial association of bacteria to the plant,
the flavonoids then induce the gene expression of nod factors.26 Nod factors induce nodule
formation and root hair curling, which can trap bacteria, giving them a home where
replication can occur (Figure 6).27 Once the bacteria have reached an optimal population
density, they penetrate the outer cell wall of the plant and form an infection thread inside
the root. This thread then spreads to other plant cells, allowing further replication to occur.
At this point, the bacteria morph into bacteroids and start synthesizing nitrogenase inside
the plant cells. Nitrogenase converts nitrogen gas into ammonium, which is a nitrogen form
that the plants can use. This whole process is thought to depend on quorum sensing, but
the exact role of quorum sensing with this symbiotic relationship is still unknown. 28
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Figure 5
Root nodulation. Bacteria attach onto root-hair curls where the
bacteria can easily replicate as it uses carbohydrates that the plant provides.
Eventually, the bacteria will penetrate through the cell wall and form a thread inside
the plant. Once inside, the bacteria will start synthesizing nitrogenase, which
converts nitrogen gas into a nitrogen source the plants can use (ammonium).
Reprinted by permission from Macmillan Publishers Ltd: [Nat. Rev. Mol. Cell Biol.]
(27), copyright (2004).

B. japonicum uses an AHL synthase, BjaI, to produce its quorum sensing molecule,
isovaleryl-homoserine lactone. Interestingly, unlike most other AHL synthases, BjaI uses
an acyl-coenzyme A (acyl-CoA) as its acyl-substrate instead of acyl-acyl carrier protein
(acyl-ACP). It is believed that an acyl-CoA utilizing synthase such as BjaI, has evolved
from a common acyl-ACP utlilizing synthase ancestor.29
AHL Synthases are Bisubstrate Enzymes
AHL synthases are bisubstrate enzymes where one substrate is conserved, Sadenosyl-L-methionine (SAM), and the other is an acyl-substrate specific for that AHL
synthase. For most of these synthases, the second substrate is an acyl-acyl carrier protein
(acyl-ACP), with the exception of a few synthases that use acyl-coenzyme A (acyl-CoA)
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as their acyl-substrate. The specificity in the substrate lies within the acyl-chain (Figure 3).
Some variations include differing chain lengths, branch points, saturated vs unsaturated,
and, as mentioned previously, acyl-ACP vs acyl-CoA. The AHL synthase transfers the
acyl-chain from the acyl-substrate to homoserine lactone head group in autoinducer
biosynthesis (Figures 3 and 7). Two other products formed during this reaction are Smethyl-5’-thioadenosine (MTA) and holo-ACP or CoA depending on if acyl-substrate used
is an acyl-ACP or acyl-CoA.
Figure 7 shows a general representation of a proposed mechanism of how AHL
synthases produce autoinducers, however, the order of which step occurs first is still
unknown. A basic amino acid or an activated water molecule is proposed to act as a general
base to deprotonate the amine group in SAM (step 1). This frees a lone pair on the amine
group, which can do a nucleophilic attack on the carbonyl carbon in the acyl-substrate
(either acyl-ACP or acyl-CoA). This is called the acylation step (step 2). Interestingly,
SAM is not used as a methyl donor, but instead forms the lactone ring. Lactonization (step
3) occurs when the carboxylate attacks the carbon next to the sulfur, closing the ring that
transforms the unstable, positively charged sulfonium ion to a stable, neutral species
(MTA). The combination of the lactonization and acylation step is what forms the
autoinducer in Gram-negative bacteria.
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Figure 7
Proposed chemical mechanism for AHL synthases. AHL synthases are
bisubstrate enzymes, where a basic amino acid or activated water molecule will
deprotonate the amine group in SAM. The nitrogen can now do a nucleophilic attack
on the thioester carbonyl carbon to complete the acylation step. Lactonization occurs
when the carboxylate within SAM does an intrinsic attack, closing the ring, and the
sugar moiety leaves. The order of which chemical steps occur first is still unknown.
Crystal Structures of LasI, EsaI, and TofI
To date, only three crystal structures of AHL synthases have previously been
studied – LasI, EsaI, and TofI.30, 31 The most conserved portion of the AHL synthases are
found within the N-terminal region. It is predicted that this highly conserved region is used
to bind with the common substrate, SAM. The C-terminal region, however, fluctuates
between the AHL synthases and is most likely the region that binds to the varying acyl-
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chain substrate. LasI binds to the longest acyl-chain (3-oxo-dodeconoyl-ACP), followed
by TofI (octanoyl-ACP), and finally EsaI (3-oxo-hexanoyl-ACP).32-33 A hydrophobic Vcleft pocket is found within all three structures where the depth of this pocket changes to
accommodate different acyl-chain lengths (Figure 8). Mutational analysis of EsaI and LasI
showed that hydrogen bonding between a threonine within the V-cleft and the 3-oxo in the
acyl-chain plays a critical role to help the enzyme differentiate between substituted and
unsubstituted acyl-chains. Towards the top of the V-cleft, there are multiple positively
charged amino acids that can electrostatically interact with the negatively charged ACP.33
Single and double mutations within the predicted ACP binding site decreased the activity
of LasI supporting the idea that electrostatic interaction is occurring between the enzyme
and ACP.30, 33 Just recently, the crystal structure of BjaI has been obtained (see chapter 3),
where one goal of this thesis is to predict some possible roles certain amino acids play in
specific recognition of isovaleryl-CoA substrate by the BjaI AHL sythase.

Figure 8
EsaI.

Crystal structures of two acyl-homoserine lactone synthases – LasI and
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Michaelis-Menten Enzyme Kinetics
A common tool used to analyze enzymes, especially when it comes to substrate
specificity, is the Michaelis-Menten equation. Under certain assumptions, the reaction
between an enzyme, E, and a substrate, S, can be represented as:
𝐸 + 𝑆 ⇌ 𝐸𝑆 → 𝐸 + 𝑃
where ES is an enzyme-substrate complex, and P is the product released after catalysis.
Furthermore, the rate of the reaction (v) is related to Km and Vmax as follows:
𝑣=

𝑉𝑚𝑎𝑥 [𝑆]
[𝑆]+𝐾𝑚

(1)

where Vmax is the maximal velocity the enzyme can catalysize the reaction, [S] is the
substrate concentration, and Km is the amount of substrate required to reach a rate that is
half of Vmax. By plotting the rate of the reaction vs substrate concentration, Vmax and Km can
be determined, as shown in Figure 9. With bisubstrate enzymes, the intital velocity
equation includes both substrates, A and B. When the substrates A and B bind to the
enzyme in a specific order, then the initial velocity equation is:
𝑣=𝐾

𝑉𝑚𝑎𝑥 [𝐴][𝐵]

𝑖𝑎 𝐾𝑏 +𝐾𝑏 [𝐴]+𝐾𝑎 [𝐵]+[𝐴][𝐵]

(2)

where Kia is the dissociation constant for substrate A in the absence of B, and Kb and Ka
are the Michaelis-Menten constants for substrate B and A, respectively, at saturating
conditions of the other fixed substrate. To simplify this equation, if one substrate is held
under saturating conditions (for example, substrate B) then it reduces down to:
𝑣=

𝑉𝑚𝑎𝑥 [𝐴][𝐵]
𝐾𝑎 [𝐵]+[𝐴][𝐵]

(3)
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which can be further reduced back to the original Michaelis-Menten equation:
𝑣=

𝑉𝑚𝑎𝑥 [𝐴]
[𝐴]+𝐾𝑎

(1)

This allows bisubstrate enzymes to be studied like single substrate enzymes as long as one
is at saturating conditions.

Figure 9
Substrate-velocity curve. Km represents the amount of substrate
concentration to reach ½ maximal velocity (Vmax) that an enzyme can function. As the
substrate concentration increases, so does the rate of the enzyme until it reaches a
point where the enzyme is saturated and cannot increase the rate any longer
(plateaus).
Thesis Objectives
The goal of this thesis is to gain a better understanding on how substrate recognition
is accomplished in BjaI, an AHL synthase found in Bradyrhizobium japonicum. Part of
understanding how AHL synthases selectively bind to specific substrates is by studying
varying types of AHL synthases and BjaI is one of the few that binds to acyl-CoAs instead
of acyl-ACPs. This thesis is subdivided in to three main sections, which are covered in
three separate chapters – SAM synthesis, measuring kcat and Km for single-point mutations
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in BjaI, and measuring kcat and Km for various acyl-CoAs and Ki for their respective
substrate analogs.
Chapter 2: SAM Synthesis
Commercially available SAM is expensive and is impure due to SAM degradation.
This has caused research labs to start synthesizing SAM in their own lab. Chapter 2
addresses some issues with synthesizing SAM and determines if this SAM can be used in
the DCPIP assay to study AHL synthase mechanisms with less background rates than the
commercially available SAM. A clean sample of SAM substrate is especially important in
assaying slow enzymes with low turnover rates, such as BjaI.
Chapter 3: BjaI Mutants
In a collaborative project with Dr. Satish Nair, specific amino acids found within
the acyl-binding pocket of BjaI (Bradyrhizobium japonicum) were mutated one at a time
and the rate of the mutated enzyme was compared to the wildtype. The roles of specific
amino acids in the recognition of isovaleryl-CoA and SAM substrates by the BjaI AHL
synthase were investigated in this chapter.
Chapter 4: BjaI Substrate Specificity
Susbtrate specificity in BjaI, as well as other AHL synthases, are poorly understood.
To understand more about substrate specificity in BjaI, the kcat and Km of similar, nonnative substrates were compared to the native substrate, isovaleryl-CoA. Since the Km
cannot be used to determine true substrate binding affinites, substrate analogs of the acylCoAs were synthesized and inhibition studies were performed to measure Ki values. In this
chapter, the most important enzymatic step (binding step (Ki), after binding (kcat), or a
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combination of both) in acyl-substrate recognition was determined by comparing the
effects on kcat and Ki between native and non-native substrates.
Conclusion
AHL synthases are potential antibacterial therapeutic targets, but designing
synthase inhibitors have been complicated with the lack of detailed mechanistic
characterization of these enzymes. To design effective inhibitors, it is critical to target only
a specific AHL synthase. BjaI is one of the few AHL synthases that binds to acyl-CoAs
instead of acyl-ACPs and can provide a more complete picture on substrate recognition.
Not only that, BjaI so far is the only AHL synthase known that binds to a branched acylchain. The purpose of this thesis is to provide more insight on how an AHL synthase, BjaI,
selectively recognizes its specific acyl-substrate.
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CHAPTER TWO: SAM SYNTHESIS
Introduction
In Gram-negative bacteria, the signaling molecules are produced from enzymes
called acyl-homoserine lactone (AHL) synthases. These are bisubstrate enzymes where one
substrate S-adenosyl-L-methionine (SAM) is conserved between all AHL synthases. SAM
is commercially available, albeit with low purity (Figure 10). Methylthioadenosine (MTA)
is one impurity commonly formed from SAM degradation, which can be an issue when
trying to perform kinetic studies on AHL synthases – MTA is also a product of these
enzymes and, therefore, can act as a product inhibitor resulting in reduced enzyme rates.
Because SAM has stereocenters, it is possible that enantiomers are present. More
specifically, the sulfur in SAM that is biologically active is the S-enantiomer, whereas the
R-enantiomer is biologically inactive.34

It is difficult to distinguish between the

enantiomers unless a chiral HPLC column is available to use. Otherwise, the actual amount
of active SAM cannot be determined.
Purity is an important factor to consider when determining what to use to perform
kinetic studies, but the activity of the enzyme with certain SAM salts must also be
considered. There are different SAM salts that are commercially available, such as SAMCl and SAM-tosylate. From previous studies, SAM-tosylate showed inhibition at high
concentrations with BmaI1 (Burkholderia mallei), whereas SAM-Cl did not have this
effect.35 However HPLC analysis revealed that SAM-tosylate is more pure than SAM-Cl.
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When choosing the appropriate commercially available substrate, these issues (inhibition
and purity) must be taken into consideration.

Figure 10
Problems with SAM degradation. A) SAM can undergo an internal
cleavage to form homoserine lactone and methylthioadenosine and undergo
hydrolysis to produce S-(5’-deoxyribosyl)-L-methionine and adenine. This is an issue
when performing kinetic studies on AHL synthases since MTA and acyl-HSL are
products of these enzymes, which can then act as product inhibitors. B) An HPLC
chromatogram was obtained from commercially available SAM showing that SAM
has degraded and therefore is not pure.
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When buying commercially available SAM, the type of SAM salt and SAM purity
has to be considered because this can effect enzyme activity. There is, however, a way to
reduce these concerns by synthesizing pure SAM using an enzyme called Sadenosylmethionine synthetase (MetK). MetK combines methionine and ATP to
synthesize SAM as shown in Figure 11. The sulfur in L-methionine will do a nucleophilic
attack on the 5’ carbon of ATP, forcing PPPi as a leaving group. Before the products are
released, MetK will hydrolyze PPPi to PPi and Pi.36,

37

MetK will only form the S-

enantiomer, so S-adenosyl-L-methionine will be the main product. A few advantages of
synthesizing SAM within the lab are as follows: 1) it eliminates the possibility of SAM
degradation during shipment, 2) only the S-enantiomer is made so the buyer does not have
to be concerned if SAM is a racemic mixture, and 3) the ability to replace the methyl group
of SAM with other alkyl chains (Figure 11). In this chapter, we discuss the efforts we took
and the challenges we encountered during the enzymatic synthesis of SAM.
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Figure 11
Enzymatic reaction to form S-adenosyl-L-methionine (SAM) using
MetK. A few advantages of synthesizing SAM are only the S-enantiomer (on sulfur)
is made and the alkyl-chain (methyl) can be varied.

Materials
All materials were supplied by Sigma Aldrich unless otherwise specified. The
MetK plasmids were generously supplied by Dr. Satish Nair from University of Illinois at
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Urbana-Champaign. Evolution 260 Bio UV-Visible Spectrophotometer, coupled with
Peltier Water Cooled Cell Changer SPE 8 W, and Sorvall Legend X1R Centrifuge,
FreeZone 2.5 Lyophilizer, Labconco, and Accela600, HPLC were from Thermo Scientific.
Two reverse phase C-18 columns were used: one was used for checking and fractioning
out large quantities of MetK (Thermo Scientific 25005-109070) on the HPLC and the other
was used to check the purity (Thermo Scientific 25002-054630) on the UHPLC.
Methods
MetK Transformation
Transformation was performed under a sterilized hood with sterile gloves and
pipette tips. After thawing on ice, 2.5 µL of plasmid was mixed with 50 µL E. coli BL21
competent cells. The mixture sat on ice for 30 mins before heat shocking it for 30 seconds
in a 42 °C water bath and then put back on ice for 2 mins. The competent cells, which now
have the plasmid in it, were diluted with 1000 µL of LB. This mini growth was incubated
with shaking at 37 °C for 1 – 1.5 hours. LB-agar plates containing kanamycin were then
streaked with varying amounts of the mini growth (10, 40, and 75 µL). The plates were
incubated at 37 °C overnight.
MetK Growth, Lysis, and Purification
In a sterilized environment, MetK cell stocks were streaked on an LB-agar plate
containing kanamycin resistance (50 µg / mL). After growing for 12 – 24 hours at 30 °C,
one colony was picked and added to LB (5 mL) containing the same final concentrations
of kanamycin. This mini growth was incubated with gentle shaking (225 rpm) at 30 °C for
12 hours. The now turbid mini growths were added to 300 mL of LB-M9 media containing
kanamycin resistance (50 µg / mL), which incubated at 37 °C with shaking (225 rpm) until
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OD600 reached 0.5 – 0.8. Once isopropyl β-D-1-thiogalactopyranoside (IPTG, 0.5 mM) was
added to induce expression, the LB with bacterial growth was incubated for another 2 hours
at 37 °C with shaking. The cells were pelleted by centrifugation at 5,000 x g for 10 – 15
mins and stored in - 20 °C overnight. The cell pellets were first incubated with BugBuster
Master Mix (5 mL / 1L growth) for 40 mins at room temperature. Then 5 – 10 mL of
loading buffer (25 mM HEPES, pH = 7.5, 0.5 M NaCl, 20 % glycerol, 5 mM TCEP, 20
mM imidazole) were added to the lysate and incubated at RT for another 5 mins. The lysate
was centrifuged at 14,000 x g for 20 mins. The supernatant was decanted into 1.5 mL NiNTA resin (Qiagen) equilibriated with loading buffer. To allow for maximum binding, the
resin and supernatant was incubated at 4 °C for 30 mins. The column was washed with
20X bed volume of loading buffer followed by another 20X bed volume of loading buffer
with 60 mM imidazole. The protein was eluted using 5X bed volumes of loading buffer
with 500 mM imidazole. The enzyme was further dialyzed using 25 mM HEPES, pH =
7.0, 0.2 mM KCl, 10 % glycerol, and 1 mM TCEP at 4 °C. These fractions were then
combined, filtered and concentrated with 10 kD Amicon spin column at 5,000 x g.
Concentration of MetK was determined using UV-Vis (280 = 40,000 M-1cm-1). The
purified protein was stored at - 80 °C in 50 mM lithium 4-morpholine-ethanesulfonate
(MES) at a pH = 6 containing 20 % glycerol.
Enzymatic SAM Synthesis using MetK
An enzyme reaction mixture containing 100 mM Tris/HCl (pH = 8.0), 200 mM
KCl, 100 mM MgCl2, 30 mM L-methionine, 20 mM ATP, and 20 – 40 µM MetK was
incubated at 37 °C for 2 – 3 hours. Completion of the reaction was monitored on the HPLC,
where ATP eluted out at 3.3 mins and SAM eluted at 4.1 mins (method - 0.2 M sodium
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acetate with a 5 % methanol gradient over 30 mins and a 200 µL / min flow rate). Once
reaction was completed, 4 M sodium acetate buffer (pH = 4.0) was added (~ ¼ of original
volume) to precipitate out MetK enzyme. The enzyme was pelleted by centrifugation at
15,000 x g for 2 mins and the supernatant was diluted with 0.2 M sodium acetate buffer,
pH = 4.0 (~ 2X original volume). To purify the protein, an Amberlite dry resin was first
soaked in equilibration buffer (0.2 M sodium acetate buffer, pH = 4.0) until it swelled to
approximately 1.5X the original volume. The resin was then transferred to a column, which
was equilibrated with 10X bed volumes of 0.2 M sodium acetate buffer (pH = 4.0). The
supernatant was poured onto the column and the run through was collected. The column
was washed with 10X bed volumes of 0.2 M sodium acetate buffer (pH = 4.0) before SAM
was eluted out with 0.1 M H2SO4 + 10 % EtOH ( pH < 1) in 1 mL fractions. The fractions
were checked on the HPLC using the same method as described before and the fractions
that contained pure SAM were combined and lyophilized. SAM was dissolved in 0.1 M
H2SO4 + 10 % EtOH at high concentrations and stored in - 80 °C. The pH was neutralized
with Tris / HCl (pH = 8.0) buffer before being used in the DCPIP assay.
DCPIP Assay
The enzymatic reaction catalyzed by BjaI was monitored by measuring the
reduction of the blue dye 2,6-dichlorophenolindophenol (DCPIP) into DCPIPH2 at 600 nm
(ε600 = 21,000 M-1 cm-1). The reaction contained final concentrations of 100 mM HEPES
(pH 7.3), 30 µM DCPIP, 0.6 µM BjaI, isovaleryl-CoA at 31 or 60 µM, and 300 µM of
either synthesized or commercially available S-adenosyl-L-methionine (SAM from Sigma
Aldrich Co.). The reactions were initiated with enzyme after a 10 min incubation period to
reduce interference of non-specific reduction of DCPIP.
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Results and Discussion
SAM is a conserved substrate between all AHL synthases, so the purity and activity
of this compound is important in order to study these enzymes. Instead of buying
commercially available SAM salts, which are impure, it is becoming a new standard to
sythesize pure SAM in the lab. For example, S-adenosylmethionine synthetase (MetK)
can enzymatically react with methionine and ATP to form SAM. However, the conditions
for this reaction can be very sensitive. The major problem was the precipitation of MetK
in the reaction buffer before SAM synthesis reaction went to completion (see methods –
Enzymatic SAM Synthesis using MetK). Since an active, soluble MetK enzyme is
absolutely necessary for SAM synthesis to proceed, we undertook multiple strategies to
determine the cause for MetK precipitation in this reaction.
Issues with MetK Precipitation
First, we tried changing the pH to see if our enzyme was precipitating due to too
low of a pH, causing disulfide bond formation, or too high of a pH. The pH was varied
from 6.5 – 9.0 and it was found that a pH between 7.0 – 8.0 worked the best. Another
reason for MetK precipitation can be attributed to high concentrations of glycerol. This
might have been due to unfavorable interactions between the glycerol, ACN, and MetK.
To reduce the amount of glycerol (MetK was stored in 20 % glycerol), the MetK solution
was filtered before adding to the reaction mixture. This did not seem to have any effect, so
the next step was to see if the enzyme can be added in aliquots. This did not work either –
preciptation still occured.
Another possibility of MetK precipitation is if disulfide bonds were forming
between the enzymes even if the pH was between 7.0 – 8.0. One way to check for this is
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by adding tris(2-carboxyethyl)phosphine (TCEP) to break apart some of these disulfide
bonds - TCEP was chosen because the originally protocol used TCEP instead of other
reducing agents such as DTT.36 Again, the results showed that it did not matter if TCEP
was present or not. Next, varying the percentage of acetonitrile (ACN) was attempted.
There were varying results, but a 0 – 10 % ACN in the reaction buffer worked slightly
better than the 20 % ACN originally reported by Lin et al.37 Another varied aspect of the
reaction buffer was the concentrations of MetK, ATP, and methionine to see if higher or
lower concentrations could help push the reaction further, or help decrease the amount of
enzyme precipitation.
What worked the best was keeping the pH between 7.0 – 8.0, MetK concentration
between 10 – 40 µM, ACN between 0 – 10 %, and having methionine in excess instead of
ATP. Unfortunately, excess methionine cannot be detected using the HPLC (the HPLC
was used to detect when the SAM reaction went to completion and to determine what
purified fractions of SAM to combine). Therefore, some methionine might be left in the
purified SAM. Although the precipation issue was never fully fixed, the reaction did
proceed. Separating two charged compounds (SAM and ATP) that were important for
determining when the reaction was complete on the HPLC was difficult. After repeated
trials, we determined the following HPLC method was effective in resolving SAM and
ATP: 0.2 M sodium acetate with a 5 % methanol gradient over 30 mins and a 200 µL/min
flow rate. ATP eluted as two peaks, one at 3.3 minutes and another at 3.8 minutes, whereas
SAM eluted only as one peak at 4.1 minutes (Figure S1). Decreasing the flow rate helped
the most with the separation of these two charged compounds.
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Issues with SAM neutralization for use in DCPIP Assay
Once SAM was successfully synthesized and purified, it was lyophilized and then
stored under acidic conditions (pH < 1) at - 80 °C to reduce degradation. As a result, SAM
had to be neutralized before performing any kinetic analysis with the DCPIP assay. Not
only is the enzymatic reaction pH sensitive, but the colorimetric DCPIP dye is also pH
sensitive – Δε600 decreases from 21 000 to 14 000, 4 000, and 2 000 M-1 cm-1 from pH 7.3
to 6, 5, and 4, respectively.38 Even if SAM was less than 10 % of the total volume, it
resulted in high background rates that used up most, if not all, of the DCPIP due to these
acidic conditions.38
Multiple attempts were made to neutralize the SAM solution, such as: dissolving
NaHCO3 or CaCO3 directly into the solution, diluting the concentrated SAM with saturated
solutions of NaHCO3 or CaCO3, or with various buffers, such as HEPES (pH = 7.3) and
Tris-HCl (pH = 7.5 and 8.0). Dissolving NaHCO3 or CaCO3 directly into the SAM solution
was not successful because it became supersaturated before the pH was increased to 7. The
buffers worked with increasing the pH, but when the synthesized SAM was compared to
the commercially available SAM within an assay, the rate of the synthesized SAM was still
lower than Sigma SAM. If SAM was lyophilized and stored in its solid form, and then
dissolved in water, the synthesized SAM would have the same rates as the commercial
SAM (Table 1). However, this was not checked for degradation over time.
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Table 1
Comparing enzymes rates of Sigma SAM with synthesized SAM in
Tris-HCl (pH = 8.0)1 and water2
Type of SAM
Synthesized
Sigma

Average rate
(µM/min)1
0.380
1.394

Relative
Percent1
27.3%
100%

Average rate
(µM/min)2
1.670
1.743

Relative
Percent2
95.8%
100%

1Synthesized

and Sigma SAM concentrations were dissolved in Tris-HCl (pH = 8.0) and were kept at 300 µM with IVCoA at 60 µM with BjaI at 0.60 µM.
2Synthesized and Sigma SAM concentrations were dissolved in water (pH ~ 7) and were kept at 300 µM with IV-CoA
at 31 µM with BjaI at 0.63 µM.

Conclusion
Synthesizing SAM within the lab is becoming the new standard, but the conditions
for synthesis must be optimized to obtain pure SAM. Various reaction conditions were
changed to see if the precipation of the enzyme would be reduced – pH, removal of
glycerol, decreasing amount of ACN, adding TCEP, and others. Eventually the synthesis
did work, but the precipitation issues were never resolved. It is critical to address the issue
of degradation of SAM into MTA, especially in regards to enzymes that use MTA as either
a substrate or product; AHL synthases fall into this catergory. It is possible to couple the
DCPIP assay with nucleosidase, but most likely there are other impurities as well that could
effect enzymatic reaction rates. However, since the synthesized SAM had the same rates
as Sigma SAM, and due to time constraints, the experiments performed in this thesis study
were continued with Sigma SAM.
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CHAPTER THREE: BJAI MUTANTS
Introduction
Four crystal structures of AHL synthases have been obtained to date, namely LasI
(apo-enzyme), EsaI (apo-enzyme), BjaI (enzyme-substrate and enzyme-inhibitor cocrystal
structures) and TofI (enzyme-inhibitor complex). The crystal structures show a dedicated
acyl-binding pocket to accommodate the acyl-chain of acyl-substrate (Figure 8). This
pocket is believed to be optimized for selective recognition of acyl-chain of the native acylsubstrate for the AHL synthase. For example, two beta-sheets combine to form a deeper,
V-shaped acyl-chain binding pocket in the 3-oxododecanoyl-ACP utlilizing LasI enzyme,
whereas this pocket is narrow in the shorter acyl-chain (3-oxohexanoyl-ACP) utilizing
EsaI. The x-ray structures for AHL synthases provide some clues for understanding the
structural basis of acyl-substrate specificity. The acyl-ACP utilizing synthases contain a
basic patch of residues that specifically recognize negatively charged acidic residues in
helix II of ACP, a phosphopantetheine recognition site and an acyl-chain binding pocket
that include a combination of the following features: a) hydrophobic amino acid residues
to stabilize the nonpolar acyl-chain of the acyl-substrate, b) amino acid residue(s) whose
side chains can donate or accept hydrogen bonds to or from the 3-oxo or a 3-hydroxy
moiety in a beta-substituted acyl-substrate, and c) amino acid residues that cap the size of
an acyl-chain fitting in this pocket (Figure 8). The acyl-CoA utilizing synthase, however,
do not contain the cluster of basic amino acid residues, but instead carry one or more
aromatic residues that may stabilize the nucleotide portion of acyl-CoA substrate.
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Mutagenesis Experiments with EsaI and LasI
Mutagenesis studies in the acyl-chain binding pocket for EsaI revealed that a
threonine amino acid (T140) in the acyl-chain pocket functions as a gate-keeper to
selectively recognize a 3-oxohexanoyl-ACP substrate instead of the unsubstituted
hexanoyl-ACP substrate. When T140 was mutated to alanine, EsaI produced twice as much
hexanoyl-HSL relative to its native signal, 3-oxo-hexanoyl-HSL. However, it was not
known if the change was due to a shift in specificity of hexanoyl-ACP over 3-oxohexanoyl-ACP or a loss of specificity.39 Further studies were done with mass spectroscopy
analysis to see if other AHL signals were being produced at lower quantities. The results
showed the T140A mutation in EsaI lead to the production of many acyl-chains, with a
huge preference of hexanoyl-HSL and some 3-oxo-hexanoyl-HSL, most likely due to
having the same chain length.40 This means the mutation lead to a loss of specificity
indicating that T140 restricts the enzyme to preferentially recognize the 3-oxo-hexanoylACP instead of the unsubstituted hexanoyl-ACP.
LasI binds to a similar, but longer 3-oxo-dodecanoyl-ACP substrate. Unlike EsaI,
the LasI active site contains two threonine residues namely T142 and T144 that could
potentially aid the recognition of a beta-keto oxygen moiety. Churchill and coworkers
transformed E. coli bacteria with several LasI mutant plasmids and the types and amounts
of acyl-homoserine lactones (AHL) synthesized by each recombinant bacteria were
measured using mass spectrometry.40 When T142 was mutated to alanine or serine, there
was a slight loss of specificity for the native substrate, but not as much of a shift when
T140 was mutated in EsaI. The T142G mutation resulted in lower production of all acylHSL, including the native signal, 3-oxo-dodecanoyl-HSL. Further studies were done to see
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if T144 was the amino acid that helped the enzyme differentiate between the native and
non-native substrates, but when T144 was mutated to valine it did not affect the ratio of
native to non-native signal production. Unfortunately, the roles of T142 and T144 in the
specific recognition of 3-oxo-dodecanoyl-ACP substrate still remains unresolved.
BjaI Crystal Structure
A few crystal structures of BjaI have now been obtained with various ligands
bound: SAH with isopentyl-CoA and MTA with isovaleryl-CoA.41 These crystal structures
helped define the SAM, pantothenic acid, and acyl-CoA binding sites, which are discussed
in further detail below. In comparison to the AHL synthase crystal structures, the Cterminal region is vey similar, but the N-terminal region has more variation. This is most
likely because LasI, EsaI, and TofI all bind to acyl-ACPs, whereas BjaI binds to an acylCoA. The crystal structure of BjaI also has similarities with a sub-clade of GNAT proteins.
Both have seven beta-sheets flanked by alpha-helices and a similar phosphopantetheinebinding domain (Figure 12).
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Figure 12
Crystal structure of BjaI. BjaI has similar phosphopantetheine-binding
domain as a sub-clade of the GNAT proteins, where it is flanked by seven beta sheets
and alpha helices.
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Figure 13
SAM binding pocket in BjaI. The SAM binding is located between α1
and α2 as well as β6 and β7. Specific amino acids that were mutated are shown and
labeled.
SAM Binding Pocket
The SAM binding pocket is located between α1 and α2 as well as β6 and β7 (Figure
13). To gain a better understanding of the SAM binding pocket, single point mutations of
specific amino acids were done on BjaI. The amino acids within the SAM pocket that were
mutated are W34, D46, M78, and R103. The nitrogen in the indole ring of W34 may be
hydrogen bonded to the oxygen within the sugar ring in SAM. The x-ray structure reveals
that W34 could also help stabilize the nucleotide portion of SAM through pi-stacking
during substrate binding. In addition, R103 and M78 is close to the amine group in SAM,
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so these may play a role orientating the amine to do the nucleophilic attack on the thioester
bond in isovaleryl-CoA.

Figure 14
Isovaleryl-CoA binding pocket in BjaI. The isovaleryl-CoA binding site
is located between α4 and α6 as well as β4, β5, β7. Specific amino acids that were
mutated are shown and labeled.
Isovaleryl-CoA Binding Pocket
The isovaleryl-CoA binding pocket is enclosed by β4, β5, β7, α4 and α6. Within this
binding pocket, W101, Y104, M139, W142, W143, and F147 were mutated to see if these
play a critical role in substrate specificity. F147 and W101 is at the bottom of the pocket
so it could restrict longer acyl-chains from binding. Just like in SAM, isovaleryl-CoA has
a nucleotide portion and it may be crucial to stabilize this ring. We hypothesize that W142
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and W143 could stack with the acyl-CoA nucleotide to facilitate acyl-substrate binding.
Y104 and M139 are closer to the top of the acyl-chain pocket and could help to orient the
sulfur in the thioester bond in order for acylation to occur (Figure 14 is the cocrystal
structure with BjaI and isopentyl-CoA, meaning the carbonyl carbon in the thioester group
is not shown).
Objectives
The purpose of this chapter is to understand how the amino acids that outline the
acyl-CoA binding pocket in BjaI aid in specific recognition of isovaleryl-CoA substrate.
Single point BjaI active site mutants were evaluated for detrimental effects in the enzyme’s
ability to recognize isovaleryl-CoA substrate to produce isovaleryl-homoserine lactone, the
quorum sensing molecule in BjaI. These studies should help us understand the molecular
basis of native substrate recognition by the BjaI enzyme.
Materials
All materials were supplied by Sigma Aldrich unless otherwise specified. The
mutant BjaI enzymes were generously supplied by Dr. Satish Nair from University of
Illinois at Urbana-Champaign. The Thermo Scientific instruments that were used are
Evolution 260 Bio UV-Visible Spectrophotometer, coupled with Peltier Water Cooled Cell
Changer SPE 8 W.
Methods
DCPIP Assay
The enzymatic reaction catalyzed by BjaI was monitored by measuring the
reduction of the blue dye 2,6-dichlorophenolindophenol (DCPIP) into DCPIPH2 at 600 nm
(ε600 = 21,000 M-1 cm-1). The reaction contained final concentrations of 100 mM HEPES
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(pH 7.3), 30 µM DCPIP, 300-400 µM S-adenosyl-L-methionine (SAM), and 0.5 – 1.5 µM
BjaI (both wild-type and mutants), with varying concentrations of isovaleryl-CoA (ranging
from 2 – 300 µM). The reactions were initiated with enzyme after a 10 min incubation
period to reduce interference of non-specific reduction of DCPIP.
In the DCPIP assays, each data point was repeated in triplicate, and the average
initial rate obtained from the slope of the progress curves was fit to substrate inhibition
equation (4) or to the Michaelis-Menten equation (1) in Prism 6.0 to obtain kinetic
constants:

𝑣0 =

𝑘𝑐𝑎𝑡 [𝐸𝑡 ][𝑆]
𝐾𝑚 +[𝑆](1+

[𝑆]
)
𝐾𝑖

(4)

where kcat, Km, and Ki refer, respectively, to the catalytic, Michaelis-Menten, and substrate
inhibition constants, and [Et] and [S] are the total enzyme concentration and substrate
concentration, respectively.
Molecular Dynamic Simulations
Molecular dynamics (MD) simulations were performed using the GROMACS 5.0.5
software package utilizing the Amber03 force-field parameter set.42-47 The crystal structure
of BjaI bound with S-adenosyl-L-homocysteine and isopentyl-CoA was used as a template
for generating initial geometries used in the MD simulations. All simulations were
performed using periodic boundary conditions with explicit solvation using a transferable
intermolecular potential 3-point (TIP-3P) potential model.48 To prepare the solvated
systems for simulation, a conjugate gradient energy minimization followed by NVT and
NPT equilibrations were performed. A 100-ps equilibration was conducted under a NVT
ensemble using a v-rescale thermostat at 300 K with coupling time constant of 0.1 ps.49, 50
A subsequent 100-ps NPT equilibration was performed using the isotropic Parrinello-
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Rahman barostat with a time constant of 1.0 ps.51 The integration time steps for both
equilibration steps and the MD simulation were set at 1 fs. All bonds were constrained to
equilibrium values using the LINCS algorithm.52 The Verlet cut-off scheme was used in
calculation of short-range coulomb and van der Waals forces, and particle-mesh Ewald for
long-range electrostatics.53,

54

The topologies for SAM and acyl-CoA inhibitors were

initially generated using Antechamber with the general AMBER force field.55, 56 Topology
and coordinate files produced by Antechamber were converted to Gromacs format using
ACPYPE (Antechamber python parser interface).57 Optimized molecular geometries and
atomic charges for the ligands were accurately determined using quantum mechanical
methods at the MP2/6-31G(d,p) level of theory.
Production MD simulations initiating from the crystal structure were performed at
50 ns durations. As the starting structure for subsequent calculations, the atomic positions
in the BjaI: isopentyl-CoA:SAM complex were averaged over the final one ns of a
representative simulation, followed by a conjugate gradient energy minimization. All
simulations involving BjaI mutants or acyl-CoA variants used this initial geometry. Point
mutations to the BjaI pdb structure were carried out using UCSF Chimera.58 Acyl-CoA
variants were generated by GaussView, and placed within the binding complex such that
the common atoms with isopentyl-CoA ligand shared initial coordinates, and with the acyl
chain extending into the BjaI acyl binding pocket. Each newly generated system was
progressed through the solvation, energy minimization, and NVT and NPT equilibration
steps proceeding 50 ns production MD simulations as described above.
An alchemical perturbative MD free energy method was used to calculate the
relative binding free energies of the acyl-CoA variants, for which unphysical intermediate
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states were used in determining the Coulomb and Lennard-Jones (LJ) contributions to the
binding energy. Ligands over a series of linear acyl-chain lengths from ethyl- to octyl-, and
two branched acyl-chains, isobutyl- and isopentyl-, were evaluated. Simulating the
transitions from real to virtual states was implemented in two steps constituting of A, B,
and C states. State A corresponds to the ligand atoms with full Coulomb and van der Waals
(vdW) interactions turned on, state B corresponds to an intermediate state for which the
partial charges on the acyl chain atoms are set to zero, and state C represents a virtual state
with the partial charges and vdW radii set to zero. Values for the relative binding free
energy, ∆∆𝐺𝑏𝑖𝑛𝑑 , were determined for ligand transitions from states A to C (decoupling)
and C to A (coupling) using the thermodynamic relationship ∆∆𝐺𝑏𝑖𝑛𝑑 = (∆𝐴𝐶𝑜𝑢𝑙
𝑏𝑜𝑢𝑛𝑑 +
𝐿𝐽
𝐶𝑜𝑢𝑙
∆𝐴𝐿𝐽
𝑏𝑜𝑢𝑛𝑑 ) − (∆𝐴𝑠𝑜𝑙𝑣 + ∆𝐴𝑠𝑜𝑙𝑣 ), where ∆𝐴𝑏𝑜𝑢𝑛𝑑 is the change in free energy of the state

transition while the ligand is bound with BjaI, and ∆𝐴𝑠𝑜𝑙𝑣 is the free energy change for the
ligand in an unbound, or solvated, environment.
Calculations of intermediate λ states were performed at non-equidistant nodes. The
partial charges of modified atoms were decreased from λ = 0 to λ = 1 through 9 steps, and
the vdW parameters were decreased from λ = 0 → 1 through 22 steps. During decoupling
of LJ interactions, soft-core potential functions were applied with αLJ = 0.5 and λ power
dependency set to 1.59, 60 A harmonic restraint with force constant of 100 kJ mol-1 nm-2 was
placed between the receptor and ligand centers of mass to prevent unreasonable
repositioning of the ligand during intermediate decoupling steps. Simulations were
performed at each λ value for 1000 ps at 0.5 fs time steps. ∂H/∂λ was saved every 10 fs for
post-processing and free-energy calculations using Bennett’s acceptance ratio (BAR)
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perturbation method.61 The first 250 ps of each λ state simulation were considered as
additional system equilibration and not used in the energy calculations.
Results and Discussion
SAM Binding Pocket
The binding pocket for SAM is located between two alpha helices and two beta
strands. The amino acids that were mutated in this binding pocket are: W34, D46, M78,
R103, and Y104. When W34 was mutated to alanine, the Km was hardly effected, but the
kcat and kcat / Km decreased by 25 and 20-fold, respectively (Table 2). When D46 was
mutated to alanine, this resulted in one of the most damaging mutations studied with 100fold decrease in kcat / Km. Looking closer at the X-ray crystal, D46 is within hydrogen bond
distance (2.88 Å) from the adenine N6 in MTA (Figure 15). Interestingly, this hydrogen
bond interaction is not shown in the docking simulation with SAM binding.

Figure 15
X-ray crystal of D46 possibly stabilizing MTA. D46 is within hydrogen
bond distance away from the adenine N6 in MTA (2.88 Å).
M78 is found within the SAM / MTA pocket where it does not seem to have any
significant interactions with either. This is supported by M78A mutation having one of the
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least effects on kcat / Km out of the mutations studied (only a 16-fold decrease). M78 may
help SAM / MTA to fit better within the pocket spacially, without interacting with either.

Figure 16
Interactions with polypeptide backbone of R103 and Y104. When these
two amino acids were mutated to alanine, it caused a 33-fold decrease in kcat. It is
possible that the mutations caused the backbone to not be in the correct position to
help orient the amine group in SAM to do the nucleophilic attack on isovaleryl-CoA.
The R103A mutation had one of the greatest impacts in kcat in this set of mutations
(33-fold decrease) and did not the effect Km. We predict that the backbone amide in R103
hydrogen bonds with the alpha-carboxylate in the 3-amino-3-carboxylpropyl group in
SAM (Figure 16). This helps to stabilize the negative charge on the carboxylate anion.
R103 also helps to position the 3-amino group of SAM in the correct orientation to do a
nucleophilic attack on the thioester carbon in IV-CoA (acylation) as well as help stabilize
the oxyanion formation that occurs during that process. Y104A also resulted in a 33-fold
decrease in kcat. The amide found in the backbone of Y104 stabilizes the carboxylate anion,
which could be the reason why these mutations had a similar effect on kcat and Km. Overall,
the mutations located within the SAM binding pocket mostly decreased the kcat and hardly
changed the Km, if at all. This could mean that these amino acids are playing a critical role

38
in orientating SAM in the correct position to perform catalysis rather than specifically
binding to SAM. The substrate-velocity curves for all mutations are shown in Figure 17.
Table 2

Kinetic Constants for BjaI Single-Point Mutants
kcat
(min-1)

Wildtype

2.70  0.16

fold
Km
fold
decrease
(μM-1)
increase
2.11  0.4

kcat / Km
(μM-1 min-1)
1.28  0.26

fold
decrease
-

W34A

Mutations in SAM Binding Pocket
25
1
0.11  0.006
1.8  0.3
0.061  0.011

20

D46A

0.13  0.02

20

11  2.2

5

0.011  0.003

100

M78A

0.13  0.002

20

1.8  0.3

1

0.072  0.12

16

R103A

0.08  0.001

33

2.0  0.3

1

0.038  0.005

33

Y104A

0.08  0.005

33

2.1  0.5

1

0.037  0.009

33

Mutations in Isovaleryl-CoA Binding Pocket
W101A

0.10  0.001

25

1.9  0.1

1

0.054  0.003

25

W101F

0.07  0.01

36

6.0  2.8

3

0.012  0.006

100

M139A

0.25  0.02

10

3.4  1.3

2

0.074  0.16

16

W142A

0.14  0.01

20

10.1  1.6

5

0.014  0.003

100

W142F

0.69  0.34

4

26  17

12

0.026  0.022

50

W143A

0.19  0.02

14

5.4  0.7

3

0.036  0.006

36

W143F

0.09  0.01

30

8  1.2

4

0.011  0.002

100

F147A

0.40  0.02

7

3.9  0.6

2

0.104  0.017

13
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Figure 17
Substrate-velocity curves for BjaI mutants. The title of each graph
reveals the mutation and concentration of enzyme used in each assay.
Isovaleryl-CoA Binding Pocket
From the crystal structure of BjaI, the binding pocket of the acyl-chain and the
pantetheine-linker can be seen located between a β-bulge on the β4 strand as well as
between two other beta strands and alpa helices (Figure 14).41 W101 is found at the bottom
of the acyl-chain pocket and does not have any direct interactions with IV-CoA; it most
likely serves as a way to discriminate from longer chained acyl-CoAs. W101A mutation
resulted in a 25-fold decrease in kcat and no change in Km (Table 2). One prediction for why
it affected the kcat is because without the snug fit, the carbonyl carbon is not placed in the
correct position for the 3-amino group in SAM to do a nucleophilic attack during acylation.
W101F mutation lead to a 36-decrease in kcat, 3-fold increase in Km, and an overall 100-
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fold decrease in kcat / Km. This was a surprising result as it was originally predicted to keep
the acyl-chain pocket approximately the same depth since tryptophan and phenylalanine
are similar in size. Therefore, computational analysis was performed to identify a possible
reason for why the W101F mutation was more detrimental than the W101A mutation.
When W101 was mutated to phenylalanine, the amino acid stabilized in a different
orientation causing it to slightly close off the acyl-binding pocket (Figure 18). This resulted
in possible steric hinderance with isopentyl-CoA and caused the acyl-chain to move
slightly out of the pocket. Overall, W101 plays a role in closing the acyl-chain binding
pocket and mutations could have lead to either an increase (W101A) or decrease (W101F)
in size.
W142 and W143 have pi-stacking intereactions with the CoA nucleotide in IVCoA; Dong et al. calls this the indole platform (Figure 19A).41 Mutations in W142 effected
the catalytic efficiency slightly more than W143 mutations – W142A and W142F resulted
in 100- and 50-fold decrease, respectively, and W143A and W143F resulted in 36- and
100-fold decrease, respectively (Table 2). This could be because W142 is the initial amino
acid that pi stacks with the isopentyl-CoA adenine ring and may help to pull it into the
isovaleryl-CoA pocket. This prediction is supported by the observation of the adenine ring
being pulled closer to W143 within 10-20 ns, which ends up getting stabilized in between
W143 and W142 (Figure 19B).

M139 is found on the side of the acyl-chain pocket and is too far away to interact
with the acyl-chain directly. This is supported by the smaller effect the M139A mutation
had on kcat / Km (16-fold decrease). F147A mutation had the least effect on catalytic
efficiency with only a 13-fold decrease. There were not any direct intereactions with the

41
acyl-chain with this amino acid either, which could be the reason why it did not affect the
catalytic efficiency as much.

A)

B)

Figure 18
Overlay of wildtype BjaI with W101F mutant. When W101 was
mutated to phenylalanine, the ring turned and closed a portion of the pocket. This
caused isopentyl-CoA to be pushed out of the acyl-binding pocket. A) is a front view
whereas B) is a side view where part of the enzyme is spliced. BjaI wildtype is shown
in blue and the W101F mutated BjaI is shown in light purple.
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Figure 19
W142 and W143 indole platform with isopentyl-CoA. A) The CoA
nucleotide in isopentyl-CoA has pi-stacking interactions with W142 (top) which could
be pi-stacking with W143 (bottom). B) After running the MD simulation for 50 ns,
the adenine ring actually inserted itself between the W142 and W143.
Possible Future Single Point Mutations:
After analyzing the crystal structure of BjaI, a few other amino acids that may play
a critical role in substrate recognition are S102, R32, and V106. S102 is another amino acid
that may be hydrogen binding with the carboxylate in SAM like R103 and Y104 (Figure
20). It is possible that there are multiple amino acids needed to align the carboxylate group
in SAM in order to position the amine group for catalysis. R32 and V106 could be
stabilizing the pantetheine linker. R32 is within hydrogen bond distance with one of the
negatively charged phosphate groups and the amide backbone of V106 is within hydrogen
bonding distance to the amide oxygen atom in the pantetheine linker (Figure 20). When
the pantetheine linker is destabilized, it could effect how the rest of IV-CoA binds as
discussed with inhibition studies in Chapter 4.
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Figure 20
Possible future amino acid mutations. S102, R32, and the backbone of
V106 are hydrogen bonding with a portion of SAM.
Conclusion
Single point BjaI active site mutants were evaluated for detrimental effects in the
enzyme’s ability to recognize isovaleryl-CoA substrate to produce isovaleryl-homoserine
lactone. In general, the single-point mutations within the SAM binding pocket decreased
the kcat without affecting the Km. One possible reason for R103 and Y104 mutants to affect
the turnover rate is these amino acids are stabilizing the carboxylate in SAM and may even
help orient the amine group for acylation. Within the isovaleryl-CoA binding pocket,
W101, W142, and W143 had the greatest impact on the catalytic efficiency. W101, along
with F147, close off the bottom of the acyl-chain pocket. Since alanine mutation of these
two residues expands the acyl-chain pocket, the isovaleryl side chain has more space to
occupy. The increased flexibility of isovaleryl-chain presumably interferes with the
formation of tight, productive [Enzyme-acyl-CoA.SAM] ternary complex necessary for
optimum positioning of SAM-amine and thioester carbonyl towards acylation step in
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catalysis. W142 and W143 are important in stabilizing the adenine ring in isopentyl-CoA
and without this, the rest of the substrate was also destabilized. Overall, the mutations
within the isovaleryl-CoA binding pocket and within the SAM binding pocket were
detrimental to the enzyme’s capability to recognize its specific acyl-substrate.
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CHAPTER FOUR: SUBRATE SPECIFICITY IN BJAI
Introduction
AHL synthases in Gram-negative bacteria produce signaling molecules to detect
when the local bacterial population reach a quorum. Most AHL synthases use a specific
acyl-ACP and SAM to synthesize these signaling molecules, while a few use a specific
acyl-CoA and SAM. While the homoserine lactone moiety is conserved, the acyl-chains in
AHLs vary depending on the type of QS signal used by a bacterium. Although it is not
clear how bacteria makes specific signal molecules for interbacterial communication, the
following scenarios could potentially explain how a bacterium might achieve this outcome:
1) The AHL synthases could differentiate between similar acyl-chain substrates and
therefore only produce one signal, 2) AHL synthases could produce multiple AHL signals,
but then nonspecific signals are selectively degraded, and 3) Fatty acid biosynthesis could
be optimized to accummulate a specific acyl-ACP in vivo to aid in specific AHL synthesis.
There is not any evidence supporting the selective degradation of signals or the
optimization of fatty acid biosynthesis pathway, but there has been some evidence
supporting the idea that AHL synthases can differentiate between native and non-native
substrates.35, 62
In order for AHL synthases to have high fidelity in signaling production, the
enzyme must be able to recognize its specific acyl-CoA / ACP. There are three possible
steps where the enzyme can differentiate between native and non-native substrates: 1) at
the binding step, 2) during catalysis, and / or 3) during product release (Figure 21). The
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acyl-ACP binding sites for EsaI, LasI, and TofI accommodate different acyl-chain lengths
due to these enzymes catalyzing different acyl-homoerine lactones with shorter or longer
acyl-chain lengths. This may be one way AHL synthases could selectively bind to its
specific acyl-substrate. It is also possible that the acyl-binding pocket can accommodate
similar substrates, but the thioester bond is not orientated correctly for catalysis to occur
(Figure 7). Lastly, the non-native substrates could be binding, and even turned over, but
the enzyme-product complex inhibits the enzyme, which slows down the rate of catalysis.
To determine if substrate specificity is occuring at the binding step or sometime after
binding, Ki and kcat values were measured and compared.

Figure 21
Three possible enzymatic steps where BjaI can differentiate between
native and non-native substrates. BjaI could be differentiating 1) at the binding step
2) during catalysis and/or 3) during product release, where A and B can represent
either IV-CoA or SAM and P, Q, and R can either be MTA, CoA, or IV-HSL.
Comparing Ki and kcat values will help determine if substrate specificity is occurring
at the binding step (Ki) and / or after binding (kcat). This figure is not meant to
represent the mechanism of substrate addition or product release; that is still
unknown.
To determine if BjaI can catalyze similar, non-native substrates, kcat was measured
for various acyl-CoAs shown in Figure 22. Additionally, substrate analogs were
synthesized to determine the approximate binding affinity of these various acyl-CoAs; the
analogs mimic the substrate except for one oxygen atom in the carbonyl. Without the
carbonyl, the amine group in SAM is less likely, if at all, to do a nucleophilic attack on that
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carbon. Since these analogs mimic the substrate, it is expected that these will bind to the
same binding site and therefore act as competitive inhibitors to the acyl-substrate. The acylCoA substrates, and consequently the substrate analogs, were selectively chosen to help us
understand substrate specificity mechanism in BjaI. Valeryl-CoA, an isomer of isovalerylCoA, can be used to determine if BjaI will differentiate between substrates that have similar
hydrophobic interactions within the acyl-binding pocket. Acetyl-, propionyl-, and
isobutyryl-CoA are a few carbons shorter than the native substrate and therefore may not
be positioned correctly for catalysis (kcat), but the V-cleft has enough room for these to
bind, so Ki might not be affected. Butyryl-CoA is the same carbon length as isovalerylCoA and will give insight on if the loss of a methyl-group in the acyl-chain impairs
catalysis (kcat) and / or the initial binding (Ki) step in AHL synthesis. Hexanoyl- and
octanoyl-CoA are a few carbons too long and is expected to not even bind within the acylCoA binding pocket due to insufficient room. Therefore, both kcat and Ki should be
dramatically affected.
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Figure 22
Structures of various acyl-CoAs and alkyl-CoAs. The native (boxed)
and non-native acyl-CoAs were used to determine kcat values (left) and the
corresponding alkyl-CoA inhibitors used to measure Ki values (right). Without the
carbonyl group, acylation cannot occur (Figure 7).
Michaelis-Menten Enzyme Kinetics and Inhibition
As discussed in chapter one, the Michaelis-Menten equation works well for one
substrate enzymes or bisubstrate enzymes where one substrate is held at saturating
conditions. When performing inhibition studies, the Michaelis-Menten equation (1):
𝑣0 =

𝑉𝑚𝑎𝑥 [𝑆]
[𝑆]+𝐾𝑚

(1)

can be rearranged into equation (5):
1

𝐾𝑚

=𝑉
𝑉

𝑚𝑎𝑥

1

× [𝑆] + 𝑉

1

𝑚𝑎𝑥

(5)

where V is the rate of the reaction, Vmax is the maximal velocity the enzyme can catalyze
the reaction, [S] is the substrate concentration, and Km is the amount of substrate required
to reach half of Vmax. By plotting inverse rate vs inverse substrate concentration, this can
be used to determine the mode of inhibition.
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There are three main modes of inhibition – competitive, uncompetitive, and mixed.
Competitive inhibitors bind to the same enzyme form as the substrate and therefore blocks
the substrate from binding. Due to the substrate competing with the inhibitor, a decrease in
the rate of the reaction is observed initially. However, Vmax does not change because high
concentrations of substrate will likely overturn the effects of the inhibitor. Since the
inhibitor and substrate are competing for the same enzyme form, there will be an increase
in Km. In the double reciprocal plot, an increase in Km with no effect on Vmax will result in
a slope change while keeping the y-intercept the same (equation 5). Uncompetitive
inhibitors, however, will bind to a different form of enzyme than the substrate and result in
intercept effects. For example, by increasing the inhibitor concentration, the amount of ES
complex will decrease as it forms ESI. This will decrease Km (it will appear the E and S
have a higher binding affinity) and Vmax will also decrease. Km and Vmax will be effected by
the same ratio, thus canceling each other out and resulting in no slope effect. It is also
possible for the inhibitor to act as both competitive and uncompetive, which is called mixed
inhibition. A special type of mixed inhibition is noncompetitive inhibition, where the
inhibitor functions as a competive and uncompetive inhibitor equally. In this scenerio, Km
is not effected, but the Vmax decreases. The Lineweaver-Burke plots of competitive,
uncompetitive, and noncompetitive are shown in Figure 23.
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[I]

[I]
[I]

1
V

1
V

1
V

1
Vmax

1
S
Competitive Inhibition
No effect on Vmax
Increase in Km

-1
Km
1
S
Uncompetitive Inhibition
Decrease in Vmax
Decrease in Km

1
S
Noncompetitive Inhibition
Decrease in Vmax
No effect on Km

Figure 23
Lineweaver-Burke plots can be used to determine mode of inhibition.
When the substrate and inhibitor bind to the same enzyme form, slope effects are
observed due to an increase in Km. Uncompetitive inhibition occurs when the
substrate and inhibitor are binding to different enzymes forms that are reversibly
connected. This effects both the kcat and Km, resulting in no slope effect, but a varied
y-intercept. Noncompetitive occurs when there are equal parts of competitive and
uncompetitive inhibition, resulting in both slope and y-intercept effects, but merges
on the same x-intercept. Retrieved on August 18, 2016 and adopted from
http://guweb2.gonzaga.edu/faculty/cronk /CHEM440/images/inhibition_Lineweaver_Burk.gif

Objective
In vivo, only specific quorum sensing molecules are observed. To determine if BjaI
acyl-CoA substrate selectivity, kcat and Ki values were measured with various acyl-CoAs
and alkyl-CoAs. The variation in the kcat and Ki values were used to predict where substrate
specificity is occuring - at the binding step (Ki), after binding (kcat), or a combination of
both – depending on which step was affected the most.
Materials
All materials were supplied by Sigma Aldrich unless otherwise specified. The
instruments used were: Excella E24 Incubator Shaker, New Brunswick Scientfic;
Evolution 260 Bio UV-Visible Spectrophotometer, Thermo Scientific coupled with Peltier
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Water Cooled Cell Changer SPE 8 W, Thermo Scientific; Sorvall Legend X1R Centrifuge,
Thermo Scientific; and FreeZone 2.5 Lyophilizer, Labconco. Two reverse phase C-18
columns were used: one was used for checking and fractioning out large quantities of MetK
(preparatory column, Thermo Scientific 25005-109070) on the HPLC and the other was
used to check the purity (analytical column, Thermo Scientific 25002-054630) on the
UHPLC.
Methods
Wildtype BjaI Growth, Expression, and Purification
In a sterilized environment, BjaI cell stocks were streaked on an LB-agar
plate containing chloramphenicol and ampicillin (50 µg / mL each). After growing for 12
– 24 hours at 37 °C, one colony was picked and added to LB (15 mL, Fisher) containing
the same final concentrations of chloramphenicol and ampicillin. This mini growth was
incubated with gentle shaking (225 rpm) at 37 °C for 12 hours. The now turbid mini
growths were added to 1 L of LB containing chloramphenicol and ampicillin resistance (50
µg / mL each), which incubated at 37 °C with shaking (225 rpm) until OD600 reached 0.5
– 0.8. Once isopropyl β-D-1-thiogalactopyranoside (IPTG, 1.0 mM) was added to induce
expression, the incubation temperature was reduced to 16 °C and grown overnight. The
following day, the cells were pelleted by centrifugation at 5,000 x g for 10 – 15 mins.
Lysing the cells required the addition of B-PER (2 mL / 1 L growth, Thermo Scientific),
DNase (40 µg / mL), RNase (40 µg / mL), and phenylmethylsulfonyl fluoride (PMSF, 1
mg / mL) to the cell pellets, which incubated with these for 15 mins at 37 °C at 225 rpm.
The lysate was centrifuged at 20,000 x g for 30 mins. The supernatant was collected and
stored in the fridge until the Ni-NTA agarose resin (Qiagen) was prepared. This column
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was equilibrated with 10X bed volumes of Buffer A (50 mM Tris-HCl, pH 7.5, 0.5 M
NaCl). To bind the protein, the supernatant was added to the column and eluted out through
gravitation. The column was washed with 10X bed volume of Buffer A with 50 mM
imidazole to help purify the protein. To elute the protein of interest, 5X bed volumes of
Buffer A with 300 mM imidazole was added to the column, which was collected in 1 mL
fractions. SDS-PAGE was used to determine which fractions contained clean BjaI. These
fractions were then combined, filtered and concentrated with 10 kD Amicon spin column
at 5,000 x g. The concentration of BjaI was determined using UV-Vis (280 = 48,500 M-1
cm-1). The purified protein was stored at - 80 °C in 50 mM lithium 4-morpholineethanesulfonate (MES) at a pH = 6 containing 20% glycerol.
DCPIP Assay
The enzymatic reaction catalyzed by BjaI was monitored by measuring the
reduction of the blue dye 2, 6-dichlorophenolindophenol (DCPIP) into DCPIPH2 at 600
nm (ε600 = 21,000 M-1 cm-1). The reaction contained final concentrations of 100 mM
HEPES (pH 7.3), 30 µM DCPIP, 300 – 400 µM S-adenosyl-L-methionine (SAM), and
approximately 0.5 µM BjaI, with varying concentrations of isovaleryl-CoA (ranging from
3 – 150 µM). The reactions were initiated with enzyme after a 10 min incubation period to
reduce interference of non-specific reduction of DCPIP. Equations (1) and (4) were used
to fit the data on Graphpad Prism 6.0.
DCPIP Assay for Inhibition Studies
IC50s were collected for each alkyl-CoA using the same set up as described in
“DCPIP Assay,” except the alkyl-CoA inhibitor was also included in the 10 min incubation
period. The concentration range for each inhibitor varied depending on the strength of

53
inhibition. Once the approximate IC50 values were determined, the inhibitor concentrations
were chosen as follows: 0 µM, two below IC50, one at IC50, and two above IC50, for a total
of six inhibitor concentrations. Varied concentrations of inhibitors were incubated with
SAM (~ 350 µM), 100 mM HEPES (pH 7.3), 30 µM DCPIP, and varying concentrations
of isovaleryl-CoA (ranging from 1 – 24 µM), for 10 mins to reduce interference of nonspecific reduction of DCPIP. The reactions were initiated with approximately 0.5 µM BjaI
and the reduction of DCPIP into DCPIPH2 at 600 nm (ε600 = 21,000 M-1 cm-1) was
monitored. Each data point was repeated twice. Equation (6) was used to fit the data and
calculate Ki and Ki’ on Graphpad Prism 6.0:
𝑎𝑝𝑝

𝑣0 =
𝑎𝑝𝑝

𝑎𝑝𝑝

where 𝑉𝑚𝑎𝑥 and 𝐾𝑚

𝑉𝑚𝑎𝑥 [𝑆]
𝑎𝑝𝑝
[𝑆]+𝐾𝑚

(6)

change depending on the mode of inhibition:

Competitive inhibition:
𝑎𝑝𝑝

𝑣0 =

𝑉𝑚𝑎𝑥 [𝑆]
𝑎𝑝𝑝
[𝑆]+𝛼𝐾𝑚

(7)

Uncompetitive inhibitor:
𝑉

𝑎𝑝𝑝

/𝛼 ′ ∙ [𝑆]

𝑚𝑎𝑥
𝑣0 = [𝑆]+𝐾
𝑎𝑝𝑝
𝑚

/𝛼 ′

(8)

Mixed inhibition:

𝑣0 =

𝑎𝑝𝑝
𝑉𝑚𝑎𝑥 /𝛼 ′ ∙ [𝑆]
𝑎𝑝𝑝
[𝑆]+𝛼𝐾𝑚
/𝛼 ′

(9)
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[𝐼]

[𝐼]

where α and α’ can be expressed as 𝛼 = 1 + (𝐾 ) and 𝛼 ′ = 1 + (𝐾 ′ ), and [I] is the inhibitor
𝑖

𝑖

concentration. The inhibitors were fitted to each type of inhibition equation listed above to
calculate Ki and / or Ki’.
Inhibitor Synthesis

R

Br

+

1:1 DMF / H2O
-

S-CoA

K2CO3

R

S-CoA

alkyl-bromide
Coenzyme A
alkyl-CoA
(excess)
(limiting)
Figure 24
Synthesis of alkyl-CoA inhibitors. Alkyl-bromides were mixed with
limiting CoA in a 1:1 DMF and water solution under basic conditions. Different alkylbromides were used to make the various alkyl-CoAs. These inhibitors were then
checked for purity on a reverse-phase analytical column on the HPLC.

To synthesize alkyl-CoAs, the respective alkyl-bromides (20 µL) was mixed into a
1:1 DMF and water solution with a pH ~ 8 – 10 adjusted using K2CO3 (Figure 24). Free
acid CoA (20 mg, 0.026 mmol) was added to the reaction under N2, which proceeded
overnight. To check for completion, DCPIP was added to a filter paper, where a small
amount of the reaction was also added. Solvent extraction with ether was used to remove
any organic reactant or side products that was formed. The sample was then filtered with a
0.22 µm syringe filter (Millex-GV) before being injected onto the HPLC (for acyl-chains
with 4 carbons or more, the method started with 95% solvent A (25 mM sodium acetate
pH = 5.0) and 5% solvent B (ACN + 0.1% TFA), and had a linear gradient for 20 mins
until it reached 30% solvent A and 70% solvent B at a flow rate of 3000 µL / min; for
smaller acyl-chains, the method was exactly the same, but with a reduced flow rate of 700
µL / min). When the peak of interest started to elute out of the column, that peak was
collected using a FoxyR1 Teledyne ISCO fraction collector. While on ice, the collected

55
fractions were combined and then N2 gas was pushed through to evaporate any organic
solvents left in solution. The solution was then stored in the - 80 °C freezer for 1 or more
hours, until ready to be lyophilized overnight. The alkyl-CoA powder was combined and
stored in the - 80 °C. To confirm that the powder was the expected alkyl-CoA, a mass
spectrum was obtained. To check for purity, a small amount was dissolved in water and
then injected into the UHPLC using the analytical column.
For the ethyl and propyl-CoA’s, the method with a slower flow rate of 700 µL /
min was used. For the rest, the method with the faster flow rate of 3000 µL / min was used.
The eluted times for each compound on the preparatory column are: ethyl-CoA 6.3 – 9.4
mins, propyl-CoA 7.9 – 11.0 mins, butyl-CoA 6.3 – 9.1 mins, isobutyl-CoA 6.0 – 7.5 mins,
pentyl-CoA 7.4 – 9.0 mins, isopentyl-CoA 7.2 – 11.0 mins, hexyl-CoA 9.3 – 11 mins, and
octyl-CoA 12.3 – 13.5 mins. The eluted times for each compound using the analytical
column are: ethyl-CoA 2.3 – 2.8 mins, propyl-CoA 3.2 – 4.2 mins, isobutyl-CoA 4.2 – 5.0
mins, butyl-CoA 4.4 – 5.2 mins, isopentyl-CoA 5.5 – 6.0 mins, pentyl-CoA 5.7 – 6.4 mins,
hexyl-CoA 6.8 – 7.5 mins, and octyl-CoA 8.2 – 8.6 mins.
Results and Discussion
Confirming BjaI and Alkyl-CoAs
Before any inhibition studies were performed, the purity and the identity of BjaI
and alkyl-CoAs had to be confirmed. BjaI is a His-tagged protein, which was purified using
Ni-NTA columns. To confirm that elutions containing only BjaI were collected, an SDSPAGE gel was ran and analyzed. The mass of the eluted protein is about 23 kDa, which
was compared to the expected mass of 23 kDa (Figure 25). The elutions with only one band
(pure BjaI) were collected, combined, and stored in 20% glyercol. To confirm the identity
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and purity of the alkyl-CoAs, a small amount of a specific alkyl-CoA was dissolved in
water and ran on a reverse-phase analytical UHPLC column. As the alkyl-chain length got
longer, the alkyl-CoA eluted at a later time. This also showed that only one major peak was
observed for each alkyl-CoA, indicating that the inhibitors were pure (Figure 26). To
confirm that the alkyl-CoAs are indeed what was expected, mass spectrometry data was
also obtained and analyzed (Figures S2-S9).

Figure 25
SDS-PAGE of BjaI. The expected weight of BjaI is 23 kDa and the
purified BjaI band was located around 23 kDa. The first, second, and third lane
represents PageRuler low range ladder, crude load (5 μL) of BjaI, and run-through
lysate (5 μL). Lanes four-six and eight-ten contains BjaI elutions (10 μL). Lane seven
contains the wash.
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Figure 26
Overlapping HPLC chromatograms of various alkyl-CoAs. Each alkylCoA only had one major peak, indicating it was pure, and the elution time was later
as the alkyl-chain got longer.
Substrate Specificity in BjaI
In vivo, there are only specific acyl-homoserine lactone (acyl-HSL) signals
detected. The substrate of interest is the acyl-CoA because this determines what type of
acyl-chain is on the HSL signaling molecule. The purpose of this chapter is to gain insight
on how substrate specificity is achieved in BjaI, one type of AHL synthase. Ki and kcat
values were measured to see if BjaI is differentiating between native and non-native
substrates at the binding step (Ki), after binding (kcat), or possibly a combination of the two.
Isovaleryl-CoA, the native substrate, has a kcat of 2.7  0.2 min-1 and butyryl-CoA is 2.3 
0.2 min-1, which is within error of each other (Table 3 and Figures 27 - 28). This indicates
that after butyryl-CoA binds to BjaI, it is being turned over just as quickly as the native
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substrate. The worst substrate, isobutyryl-CoA, has a turnover rate of 0.4  0.1 min-1, which
is approximately a 7-fold decrease from the native substrate. The lack of major changes in
the kcat for most analogs suggests that the substrate binding step could play a major role in
𝑎𝑝𝑝
BjaI catalysis. The 𝐾𝑚
values, determined using Prism 6.0, showed a lot more variance.

To determine binding affinities, alkyl-CoA’s were synthesized and used to measure and
compare Ki values.
Table 3
SAM

Kinetics constants of various acyl-CoA substrates measured with fixed
𝒂𝒑𝒑

𝒂𝒑𝒑

Substrate

𝑲𝒎 (M)

𝒌𝒄𝒂𝒕 (min-1)

Isovaleryl-CoA
Valeryl-CoA
Butyryl-CoA
Isobutyryl-CoA
Hexanoyl-CoA
Octanoyl-CoA
Propionyl-CoA

2.1  0.4
3.1  0.2
8.7  1.2
5.3  0.8
9.1  3.0
NDa
86  17

2.7  0.2
1.1  0.1
2.3  0.2
0.4  0.1
0.9  0.1
ND
1.5  0.1

aND

𝒂𝒑𝒑

𝒂𝒑𝒑

𝒌𝒄𝒂𝒕 / 𝑲𝒎
(M-1 min-1)
1.286  0.263
0.355  0.039
0.264  0.043
0.075  0.022
0.098  0.034
ND
0.017  0.003

Fold decrease
𝒂𝒑𝒑
𝒂𝒑𝒑
(𝒌𝒄𝒂𝒕 / 𝑲𝒎 )
3.6 fold
4.9 fold
17.1 fold
13.1 fold
75.6 fold

= not determined

Figure 27
Substrate-velocity curves for various acyl-CoAs. Notice that substrate
inhibition was observed for both valeryl(C5)- and isovaleryl(isoC5)-CoA.
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kcat for Specified Acyl-CoAs with BjaI
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Figure 28
Bar graph of kinetic constants for various acyl-CoAs. The catalytic
efficiency of the enzyme with non-native acyl-substrates decreased relative to the
native substrate. However, it seems that the kcat is not the only cause for this variation.
Mixed Inhibition

Inhibition studies were performed and the data was fitted using Prism 6.0 (equations
6-9). It was hypothesized that the substrate analog inhibitors would be competitively
binding for the isovaleryl-CoA binding pocket since the analog is only missing one oxygen
atom, but instead the substrate analogs showed mixed inhibition (Figures 29-32), except
for isobutyl-CoA. Further analysis (t-tests) were done to check if slope and y-intercept
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changed significantly with increase in concentration of inhibitor. With the exception of
isobutyl-CoA, there was a significant change in slope and y-intercept, concluding that these
are mixed inhibitors (Figures 31-32). Isobutyl-CoA only had a significant change in slope,
which suggests that this is a competitive inhibitor.
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Figure 29
Inhibition curves for BjaI. Longer alkyl-chains, like octyl-CoA and
hexyl-CoA, were able to inhibit better than shorter alkyl-chains, like isobutyl-CoA.
Propyl- and ethyl-CoA were so weak that they did not show inhibition until > 3
mM. Ki and Ki’ values are shown in Table 4.
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Figure 30
Double-reciprocal plots of all six inhibitors studied with BjaI. IsobutylCoA was the only inhibitor to show competitive inhibition, whereas the rest showed
mixed inhibition.
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Figure 31
Secondary plot of intercept effects. By plotting the y-intercept against
inhibitor concentrations, it was confirmed that there was or was not a significant
intercept effect, validated by t-tests. The only secondary plot that did not show
significant slope effect was isobutyl-CoA.
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Figure 32
Secondary plots of slope effect. To confirm if there was a significant
change in slope, slope was plotted against inhibitor concentration and analyzed using
t-tests.
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Even though the alkyl-CoA’s were synthesized as substrate analogs, mixed
inhibition was observed for all inhibitors. The Ki values are due to isovaleryl-CoA and the
alkyl-CoA competitively binding for the same enzyme form. Since the order of substrate
addition is unknown, this could be occuring with the enzyme or [Enzyme-SAM] complex
(Scheme 1). It is predicted that Ki’ can represent a few different or even a combination of
different enzyme-inhibitor complexes: [Enzyme-Inhibitor] or [Enzyme-IsovalerylCoA.Inhibitor] complex where the inhibitor could be binding in the SAM binding pocket
and [Enzyme-product.Inhibitor] complex where the inhibitor could be binding in either the
MTA and / or CoA product pocket.
Scheme 1 is used to help explain which complexes are possible for the inhibitor to
bind and does not necessarily portray the enzyme mechanism; the mechanism is still
unknown. A possible explanation for why the alkyl-CoAs are binding to multiple enzyme
forms is because the inhibitors have a common structure (adenosine) to SAM, CoA and
MTA which may allow the alkyl-CoA to bind to any of these pockets (Figure 33). This is
supported by the observation of substrate inhibition at high concentrations (Figure 27),
where IV-CoA could be binding to the MTA and / or CoA product binding pocket. Further
studies are necessary to determine which enzyme form the inhibitor is binding with respect
to Ki. One that is currently in progress is fluorescence quenching with SAM and isovalerylCoA where Kd can be determined. If Kd for isovaleryl-CoA is larger with SAM than it is
without SAM, then this indicates that isovaleryl-CoA binds first. If isovaleryl-CoA binds
first, then Ki is the dissociation constant for the inhibitor binding directly with BjaI. If the
reverse is found, then Ki is the dissociation constant for the inhibitor binding with the
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[Enzyme-SAM] complex. In either scenario, Ki is the dissociation constant for inhibitor
binding to the same enzyme form that binds the acyl-CoA substrate.
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Figure 33
Common structure between substrates and products for BjaI. MTA,
SAM, and the alkyl-CoAs all have a nucleotide base structure present in the molecule.
This could allow for the alkyl-CoA to bind not only to the acyl-CoA binding pocket,
but also to the SAM and MTA binding pockets as well, resulting in mixed inhibition.
E-SAM-I
EQR-I

ER-I

E-SAM
E-I

E-SAM-IV-CoA

E

EPQR

EQR

ER

E

E-IV-CoA

E-IV-CoA-I

Scheme 1
Representative kinetic scheme showing possible enzyme forms for
inhibitor binding. It is feasible for the alkyl-CoA inhibitors to bind to multiple enzyme
forms, resulting in mixed inhibition. (This scheme is used solely to help explain which
complexes are possible for the inhibitor to bind and does not necessarily portray the
enzyme mechanism). Ki would result when the inhibitor and IV-CoA are binding to
the same form of the enzyme, which could be E or the E-SAM complex. The Ki’ would
mostly comprise of the inhibitor binding to the EQR or ER complex. (P, Q, and R can
represent MTA, IV-HSL, or CoA) or it is possible that the inhibitor binds to the EIV-CoA complex.
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Prism 6.0 (equation 9) was used to determine the Ki values for various substrate
analog inhibitors to measure the approximate binding affinities of their corresponding acylCoA to BjaI. Isopentyl-CoA, which is the substrate analog to the native substrate, has a Ki
of 14  5 µM, whereas the worst detectable inhibitor, isobutyl-CoA, has a Ki of 259  87
µM (Table 4 and Figure 34). The difference in binding affinity between isopentyl-CoA and
isobutyl-CoA is approximately a 20-fold decrease, which is greater than the 7-fold decrease
observed for the kcat values. Interestingly, pentyl-CoA has the same binding affinity to BjaI
as its isomer, isopentyl-CoA. One possible explanation for why both alkyl-CoAs have the
same approximate binding affinity is because these have the same number of carbons and
therefore have similar hydrophobic interactions within the binding pocket. What separates
valeryl-CoA as a worse substrate than isovaleryl-CoA is the decrease in kcat. Since valerylCoA has a longer straight chain length, the carbonyl group might not be positioned
correctly for the amine group in SAM to do a nucleophilic attack, thus resulting in a
decrease in catalysis (Figure 7). Another substrate analog that had similar binding affinity
is butyl-CoA (Ki = 62 ± 14, a 4.4-fold increase) and, on top of that, the kcat was within error
of each other. This suggests that BjaI only has a modest preference for the branched
substrate over the straight chain analog.

Table 4
model

Kinetic constants determined from Prism using the mixed inhibition

Inhibitor

Ki (M)

Isopentyl-CoA
Pentyl-CoA
Butyl-CoA
Isobutyl-CoA
Hexyl-CoA
Octyl-CoA

14  5
14  3
62  14
259  87
51  18
105  24

Fold
increase
1
4.4
18.5
3.6
7.5

Ki’ (M)
137  106
162  85
746  397
561  337
284  197
737  343

Fold
increase
1.2
5.4
4.1
2.1
5.4

Ki’ / Ki
ratio
9.8
11.6
12.0
2.2
5.6
7.0
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Inhibition if BjaI with Various Alkyl-CoAs
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Figure 34
Bar graph of inhibition constants for various alkyl-CoAs. Ethyl- and
propyl-CoA were also studied, but these were such poor inhibitors that the Ki values
could not be determined. Variation in the Ki values are more prominent than in kcat,
with the exception of pentyl-CoA.
The binding affinity of longer and shorter alkyl-chains show that BjaI does
differentiate between too short and too long alkyl-CoAs. Hexyl-CoA and octyl-CoA have
larger Ki values in comparison to isopentyl-CoA, indicating the binding affinities of these
alkyl-CoAs have decreased. When comparing the longer alkyl-chains (hexyl and octyl) to
the shorter chains (ethyl, propyl, isobutyl), the longer alkyl-chains bind better. For all alkylCoAs, IC50s were measured to get an approximate Ki before moving into inhibition studies,
but for ethyl-CoA and propyl-CoA it took millimolar concentrations to reduce the rate by
even 50%. Therefore, these were such poor inhibitors that inhibition studies were not
performed on either of these. Originally, we hypothesized that shorter alkyl-CoAs would
be able to bind because they have room in the acyl-binding pocket whereas the longer
chains would not fit. Therefore, computational studies were done to gain a better
understanding of why shorter alkyl-CoAs were such poor inhibitors.
By using computational methods, theoretical change in Gibbs free energy (ΔG)
were calculated for all alkyl-CoAs. The shortest alkyl-CoAs, ethyl- and propyl-CoA,
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showed positive ΔGbinding, indicating that the binding of these short chains are not
energetically favorable. One possible explanation for why the binding was so poor for the
shorter chains is because these have too many degrees of freedom and consequently does
not bind well within the acyl-binding pocket. Since the alkyl-chain is not locked down into
the acyl-pocket, it disrupts the binding of the pantetheine linker and the CoA as well (Figure
35C). For the longer alkyl-chains, like hexyl-CoA and octyl-CoA, the binding of the alkylchain was sufficient enough to not disrupt the binding of the pantetheine linker and the
CoA, which is one possibility for why these were better inhibitors than the short alkylchains. However, these alkyl-chains are too long to fit into the acyl-binding pocket, which
forced them to bind to an alternative pocket (Figure 35B). This still allows for sufficient
hydrophobic interactions to occur between the alkyl-chain and the hydrophobic amino
acids, but it is not ideal.

Figure 35
BjaI bound with various alkyl-CoAs. A) Isopentyl-CoA fits snug into
the acyl-binding pocket of BjaI whereas B) octyl-CoA is too long and finds an
alternative pocket (circled), thus increasing Ki. C) Propyl-CoA starts off in the acylbinding pocket, but because the alkyl-chain is only three carbons long, there are not
enough interactions with the alkyl-chain and the binding pocket to stabilize it. This
results in disrupted interactions between BjaI and the rest of the substrate (circled)
and it eventually dissociates.
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Conclusion
In conclusion, BjaI predominately differentiates between native and non-native
substrates at the binding step. Shorter chains did not bind well at all and this could be due
to a lack of hydrophobic interactions occuring within the acyl-binding pocket that holds
the alkyl-chain in place. Without the alkyl-chain secured in the binding pocket, this causes
disruption in the binding with the pantetheine linker and CoA. Longer alkyl-chains, like
hexyl- and octyl-CoA, can still bind within the pocket allowing the linker and CoA to bind
well. However, the alkyl-chains have to find room in between amino acids since the pocket
is not deep enough to accommodate the longer chain. For similar acyl-CoAs, it seems that
BjaI uses a combination of both the binding and catalysis steps to help differentiate
between acyl-CoA substrates. Even though the inhibitors are substrate analogs, all of the
alkyl-CoAs showed mixed inhibition, except isobutyl-CoA. The inhibitor, SAM, MTA,
and CoA all have a similar structure, the adenosine, which then allowed the inhibitor to
bind to multiple enzyme forms. This is supported by substrate inhibition observed in
substrate-velocity curves with IV-CoA.
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THESIS CONCLUSION
AHL synthases have potential as antibacterial therapeutics, but designing synthase
inhibitors have been complicated with the lack of detailed mechanistic characterization of
these enzymes. BjaI, an acyl-homoserine lactone synthase found in Bradyrhizobium
japonicum, was studied for substrate recognition. Ideally, while performing these studies,
it would be best to use a purer SAM sample than what is commercially available at this
time. This is because AHL synthases already have low enzyme rates and, on top of that,
SAM degrades into products, which may lead to unwanted product inhibition. When SAM
was synthesized in our lab, there was not any difference in the enzyme rates in comparison
to commercially available SAM. Therefore, substrate recognition studies were continued
with Sigma SAM.
Single point BjaI active site mutants were evaluated for detrimental effects in the
enzyme’s ability to recognize and catalyze isovaleryl-CoA and SAM. Our studies
demonstrate that the entire substrate binding pocket (both acyl-CoA and SAM) in BjaI is
optimized for specific recognition of native, isovaleryl-CoA substrate. Furthermore,
enzyme mutants that lead to the formation of a less-productive, nonoptimal ternary
complex were found to be defective in recognizing the native isovaleryl-CoA substrate. In
conclusion, the decreased catalytic efficiency for every mutant in this substrate recognition
pocket signifies the importance of this amino acid cluster towards the formation of a
productive enzyme-substrate ternary complex, conducive for catalysis.
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To determine if BjaI is selectively binding to its specific acyl-CoA substrate, kcat
and Ki values were measured of various acyl-CoAs and alkyl-CoAs, respectively. For
alkyl-chains that were either too short or too long, BjaI predominately differentiates
between native and non-native substrates at the binding step. However, with similar acylCoAs, BjaI relies on both the binding and catalysis steps to recognize its native substrate.
Even though the inhibitors are substrate analogs, all but one of the alkyl-CoAs showed
mixed inhibition; this is probably due to the inhibitor, SAM, MTA, and CoA sharing a
common adenosine moiety in their structures. This hypothesis is also supported by
substrate inhibition that was observed in substrate-velocity curves with isovalerylCoA.This thesis is the first systematic investigation on the molecular basis of acyl-substrate
recognition in an acyl-homoserine lactone synthase. The tools used in this study can be
broadly applied to conduct mechanistic investigations in other AHL synthases to discover
quorum sensing specific inhibitors.
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SUPPLEMENTAL INFORMATION

Figure S1
HPLC spectra of ATP and SAM separation. Both ATP and SAM are
charged compounds, which makes it difficult to separate on the HPLC. A method was
optimized for the separation of the two compounds, where the first peak is ATP (split
into two peaks) and the second peak is SAM.
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Mass spectroscopy data was obtained to confirm the expected alkyl-CoA was
synthesized (Figures S1 - S8). The expected weights were calculated using ChemDraw.
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Figure S10 Fluorescence quenching with pentyl-CoA and BjaI. Fluorescence data
is currently being collected to determine if SAM or alkyl-CoA is binding first based
on their Kd values. Collected by John Taffin.

